Research Project
Grant-in-Aid for Young Scientists (B)
In this study, we investigated the methylation status of MGMT, CDKN2A, DAPK1 and LINE1 promoters, and the association with clinicopathological features, response to treatment and clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system (PCNS-DLBCL) treated with high-dose methotrexate plus radiation therapy (HD-MTX + RT). Pyrosequencing was used to determine methylation rate of these genes, and statistical analysis was performed in groups dichotomized by median of these rates. We demonstrated that 1) LINE1 and DAPK1 hypomethylation could be useful predictors of favorable survival in patients with PCNS-DLBCL treated with HD-MTX+RT. 2) CDKN2A and DAPK1 hypomethylation may predict clinical response to HD-MTX treatment prior to RT, while there was no association between response to the treatment and methylation status of LINE1 and MGMT.
All 2015 2014 2013 2012
All Journal Article (10 results) (of which Peer Reviewed: 8 results, Open Access: 2 results) Presentation (9 results)
J Histochem Cytochem.
Volume: 63 Issue: 3 Pages: 217-227
10.1369/0022155414563800
Hematol Oncol
Volume: Epub Ahead of Print Issue: 1 Pages: 9-16
10.1002/hon.2162
120005981361
J Neurol
Volume: 261 Issue: 12 Pages: 2314-2318
10.1007/s00415-014-7500-y
Breast Cancer Res Treat.
Volume: 144 Issue: 2 Pages: 249-61
10.1007/s10549-014-2867-0
120005600744
Cancer Sci
Volume: 105 Issue: 1 Pages: 81-8
10.1111/cas.12302
120005411143
PLoS One.
Volume: 8 Issue: 10 Pages: e76791-e76791
10.1371/journal.pone.0076791
120005348196
Breast Cancer Res
Volume: 15
Neuropathology
Volume: 32 Issue: 6 Pages: 647-653
10.1111/j.1440-1789.2012.01315.x
120005356854
Internal Medicine
Volume: 51 Pages: 1043-1047
Ophthalmology
Volume: 119 Pages: 1083-1084